Natural killer cells: a review of manufacturing and clinical utility.
about
Natural Killer Cells for Therapy of LeukemiaThe Application of Natural Killer Cell Immunotherapy for the Treatment of CancerNatural killer cell biology: an update and future directionsImproving the outcome of leukemia by natural killer cell-based immunotherapeutic strategiesUnderstanding of molecular mechanisms in natural killer cell therapyNatural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspectiveDevelopment of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line.Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapyRevving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Present and Future of Allogeneic Natural Killer Cell TherapyIn vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocolRetargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity.Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Engineering Natural Killer Cells for Cancer Immunotherapy.Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property.Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibodyProtective effect of hydroferrate fluid, MRN-100, against lethality and hematopoietic tissue damage in γ-radiated Nile tilapia, Oreochromis niloticus.Natural killer cell therapy for cancer: delivering on a promise.Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer.NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?Natural killer cells and tumor metastasis.Influence of autologous dendritic cells on the in-vitro expansion and functions of peripheral blood NK cells.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesExpression of CD94 by -differentiated NK cells correlates with the and acquisition of cytotoxic featuresThe Molecular Imaging of Natural Killer Cells
P2860
Q26745906-A61B8499-21A1-4620-A827-D88D007B4408Q26774678-075CC1E1-9224-4EF9-834C-63A325E660D6Q26830512-E4BABAFA-CA3E-4913-A893-5EC6EC8047B1Q26996660-BE86D69F-2CBB-4D08-A1BA-119C7C22A5B4Q28086976-61DC1ADB-FC73-4D4C-B82E-C48B2865093AQ34180695-C3DF6069-9D77-4E89-88E4-885244134ED3Q34302464-7B8160D8-D920-4006-9B74-5BC8A3948B0BQ34712771-B3EE72DD-DB0C-4BFF-B402-97CE907D5394Q35600095-CEB21E24-0490-4ABB-9B30-7D3A9406F43FQ35677351-5AA1604F-EBDB-495D-AE52-733935339128Q35803534-09C2158B-AE98-4179-A124-CB26A562652EQ36463830-35DF6801-BBFF-4472-A050-0220A82C9627Q36850695-F2433138-6973-4EAF-8E52-BE4E92B7F5D5Q37434670-FB87B7DC-D560-4584-B709-AC517E4EDDC0Q37737545-2FFC0897-ED65-459C-81A8-5980960582FDQ38670431-94A6FEE7-73A7-49D8-B0CB-BC5AC0D4AD59Q39408704-A3AFE9B1-8D76-4499-AA2E-8B498878F555Q41097112-9351F3CB-C49B-4DA5-9C71-2280EFAE5B33Q41321384-E6716993-317E-4D66-9071-B9EF6A75C0BBQ42590525-B2CE60E5-DDD2-4A6E-A60F-3D7A97E03702Q44360875-6492674B-54EF-4CAA-816F-07D1E5CEED09Q46677873-3E092E5A-F934-43A2-9A03-46574A642621Q47570438-E7C50C62-9A2F-407A-9DB2-05756C29A719Q48130583-A3ED713A-7323-49C7-AE81-CA368982A45BQ51034109-A28E21DD-D1D7-4804-9DC2-F4451511BD32Q57300237-EAA78CE3-F4C0-4F89-844A-7D5CC159F447Q58125336-08632B12-E97A-4B1A-90A8-7A0E7997DA2EQ58751470-D1C22BAC-CAA9-4CC9-A95D-E140F540CBF6
P2860
Natural killer cells: a review of manufacturing and clinical utility.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Natural killer cells: a review of manufacturing and clinical utility.
@en
type
label
Natural killer cells: a review of manufacturing and clinical utility.
@en
prefLabel
Natural killer cells: a review of manufacturing and clinical utility.
@en
P2860
P1433
P1476
Natural killer cells: a review of manufacturing and clinical utility
@en
P2093
David H McKenna
Scott A Koepsell
P2860
P304
P356
10.1111/J.1537-2995.2012.03724.X
P577
2012-06-07T00:00:00Z